Three Scientists Share Nobel Prize for Hepatitis C Research
Nobel Committee described their work as 'a landmark achievement in our battle against viral infections'
MONDAY, Oct. 5, 2020 (HealthDay News) -- Two U.S. researchers and a British scientist have been awarded the 2020 Nobel Prize in physiology or medicine for major contributions to the fight against blood-borne hepatitis.
Hepatitis C causes 400,000 deaths worldwide each year, The Washington Post reported.
The three recipients are: Harvey Alter, a clinical scientist at a U.S. National Institutes of Health blood bank; Charles Rice, of Washington University in St. Louis; and British-born virologist Michael Houghton.
The researchers' work was described by the Nobel Committee as "a landmark achievement in our battle against viral infections," The Post reported.